D. DeAngelis

Recent infection testing algorithm (RITA) applied to new HIV diagnoses in England, Wales and Northern Ireland, 2009 to 2011.

A. Charlett, H. Ward, O. N. Gill, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Risk of paediatric multisystem inflammatory syndrome (PIMS-TS) during the SARS-CoV-2 alpha and delta variant waves: National observational and modelling study, 2020–21, England

R. Viner, S. Ladhani, P. Birrell, 2022, Frontiers in Pediatrics.

Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: Active, prospective national surveillance, January-March 2022, England

S. Ladhani, M. Ramsay, P. Birrell, 2023, Journal of Infection.

Estimating adult HIV prevalence in the UK in 2003: the direct method of estimation

C. Mercer, A. Johnson, K. Fenton, 2006, Sexually Transmitted Infections.

The fall in HIV infections in MSM in England during 2012 through 2016: When did it begin and what caused it?

F. Brizzi, H. Mohammed, P. Birrell, 2018 .

Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England

S. Bhatt, S. Flaxman, W. Hinsley, 2022, SSRN Electronic Journal.

Risk of Paediatric Multisystem Inflammatory Syndrome (PIMS-TS) During the SARS-CoV-2 Alpha and Delta Variant Waves: National Observational Study, 2020-21, England

R. Viner, S. Ladhani, M. Semple, 2022, SSRN Electronic Journal.

Incidence estimation using a single cross‐sectional age‐specific prevalence survey with differential mortality

M. Sweeting, R. Lindfield, D. DeAngelis, 2014, Statistics in medicine.

Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992–2013

Ross J. Harris, J. Parry, J. McVeigh, 2016, Journal of acquired immune deficiency syndromes.

Cost effectiveness of interferon α or peginterferon α with ribavirin for histologically mild chronic hepatitis C

Jennifer A. Roberts, R. Grieve, H. Thomas, 2005, Gut.